Phase I and pharmacodynamic study of Triapine ( R), a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia

Author: Giles F.J.   Fracasso P.M.   Kantarjian H.M.   Cortes J.E.   Brown R.A.   Verstovsek S.   Alvarado Y.   Thomas D.A.   Faderl S.   Garcia-Manero G.   Wright L.P.   Samson T.   Cahill A.   Lambert P.   Plunkett W.   Sznol M.   DiPersio J.F.   Gandhi V.  

Publisher: Elsevier

ISSN: 0145-2126

Source: Leukemia Research, Vol.27, Iss.12, 2003-12, pp. : 1077-1083

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content